251 results on '"Lingwood, Daniel"'
Search Results
2. Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses
3. Engaging an HIV vaccine target through the acquisition of low B cell affinity
4. Antibody-mediated NK cell activation as a correlate of immunity against influenza infection
5. An Approach for Antigen-Agnostic Identification of Virus-Like Particle-Displayed Epitopes that Engage Specific Antibody V Gene Regions
6. Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination
7. A modular platform to display multiple hemagglutinin subtypes on a single immunogen
8. Antigen identification and high-throughput interaction mapping by reprogramming viral entry
9. An epitope-enriched immunogen expands responses to a conserved viral site
10. Repeated vaccination with homologous influenza hemagglutinin broadens human antibody responses to unmatched flu viruses.
11. A VRC13-like bNAb response is associated with complex escape pathways in HIV-1 envelope
12. Lupus-associated innate receptors drive extrafollicular evolution of autoreactive B cells
13. A modular platform to display multiple hemagglutinin subtypes on a single immunogen
14. Heterologous sarbecovirus receptor binding domains as scaffolds for SARS-CoV-2 receptor binding motif presentation
15. Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection
16. Respiratory viruses: New frontiers—a Keystone Symposia report
17. Engineered cell entry links receptor biology with single-cell genomics
18. Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design
19. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses
20. Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus
21. Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
22. Humoral responses to the SARS-CoV-2 spike and receptor binding domain in context of pre-existing immunity confer broad sarbecovirus neutralization
23. In vitro reconstitution of B cell receptor–antigen interactions to evaluate potential vaccine candidates
24. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
25. Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting
26. Mannose-binding lectin and complement mediate follicular localization and enhanced immunogenicity of diverse protein nanoparticle immunogens
27. Lateral sorting in model membranes by cholesterol-mediated hydrophobic matching
28. Palmitoylation regulates raft affinity for the majority of integral raft proteins
29. Lipid Rafts as a Membrane-Organizing Principle
30. Order of Lipid Phases in Model and Plasma Membranes
31. Plasma Membranes Are Poised for Activation of Raft Phase Coalescence at Physiological Temperature
32. A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity
33. Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses
34. Systematic discovery of receptor-ligand biology by engineered cell entry and single-cell genomics
35. Public Immunity: Evolutionary Spandrels for Pathway-Amplifying Protective Antibodies
36. Antigen identification and high-throughput interaction mapping by reprogramming viral entry
37. Engineering an Antibody V Gene-Selective Vaccine
38. Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival
39. Allelic polymorphism gates vaccine amplification of a human broadly neutralizing response against influenza virus
40. Structural and genetic basis for development of broadly neutralizing influenza antibodies
41. Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motif
42. Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
43. The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells
44. Modeling and Manipulating Antibody Response Against Influenza and Coronavirus Spike Proteins and Exploring their Role in Directing Spike Evolution
45. COVID-19-neutralizing antibodies predict disease severity and survival
46. Mannose-Binding Lectin and Complement Mediate Follicular Localization and Enhanced Immunogenicity of Diverse Protein Nanoparticle Immunogens
47. Engineered Receptor Binding Domain Immunogens Elicit Pan-Coronavirus Neutralizing Antibodies Outside the Receptor Binding Motif
48. Rationally Designed Immunogens Enable Immune Focusing Following SARS-CoV-2 Spike Imprinting
49. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues
50. Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motif
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.